The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Concepts and applications of molecular similarity
Johnson, M. A., & Maggiora, G. M. (1990) · Wiley eBooks · Cited by 1,301
Integration of virtual and high-throughput screening
Bajorath, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd941 · Cited by 930
Self-citationSimilarity-based virtual screening using 2D fingerprints
Willett, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.005 · Cited by 849
On Outliers and Activity CliffsWhy QSAR Often Disappoints
Maggiora, G. M. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060117s · Cited by 728
Brown, R. D., & Martin, Y. C. (1996) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9501047 · Cited by 625
Molecular similarity: a key technique in molecular informatics
Bender, A., & Glen, R. C. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409813g · Cited by 614
Rush, T. S., Grant, J. A., Mosyak, L., & Nicholls, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040163o · Cited by 600
Das, K., Clark, Lewi, P. J., Heeres, J., de Jonge, M. R., Koymans, L. M. H., Vinkers, H. M., Daeyaert, F., Ludovici, D. W., Kukla, M. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030558s · Cited by 514
Why do we need so many chemical similarity search methods?
Sheridan, R. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02411-x · Cited by 412 · cited 1×
“Other questions include why does the relative performance of similarity methods generally depend on compound classes [ 9 ], and why do all methods not succeed (or fail) equally? These questions can be answered by taking into account that the nature of SARs depends on the chosen molecular representations and the refere…”
BackgroundMolecular Field Extrema as Descriptors of Biological Activity: Definition and Validation
Cheeseright, T., Mackey, M., Rose, S., & Vinter, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050357s · Cited by 399
Cited by
Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
Bajusz, D., Rácz, A., & Héberger, K. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0069-3 · Cited by 1,621
Gómez-Bombarelli, R., Aguilera-Iparraguirre, J., Hirzel, T. D., Duvenaud, D., Maclaurin, D., Blood-Forsythe, M. A., Chae, H. S., Einzinger, M., Ha, D.-G., Wu, T., et al. (2016) · Nature Materials · doi:10.1038/nmat4717 · Cited by 1,060
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Molecular fingerprint similarity search in virtual screening
Cereto-Massagué, A., Ojeda, M. J., Valls, C., Mulero, M., Garcia-Vallvé, S., & Pujadas, G. (2015) · Methods · doi:10.1016/j.ymeth.2014.08.005 · Cited by 846
Machine-learning approaches in drug discovery: methods and applications
Lavecchia, A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.012 · Cited by 784
Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
Brenk, R., Schipani, A., James, D., Krasowski, A., Gilbert, I. H., Frearson, J., & Wyatt, P. G. (2008) · ChemMedChem · doi:10.1002/cmdc.200700139 · Cited by 709
Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A., & Giovanni, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990001 · Cited by 686
Molecular Similarity in Medicinal Chemistry: Miniperspective
Maggiora, G., Vogt, M., Stumpfe, D., & Bajorath, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401411z · Cited by 666
Self-citationExploiting drug-disease relationships for computational drug repositioning
Dudley, J. T., Deshpande, T., & Butte, A. J. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr013 · Cited by 524
mVOC: a database of microbial volatiles
Lemfack, M. C., Nickel, J., Dunkel, M., Preissner, R., & Piechulla, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1250 · Cited by 476
Janet, J. P., & Kulik, H. J. (2017) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.7b08750 · Cited by 289
Quo Vadis, Virtual Screening? A Comprehensive Survey of Prospective Applications
Ripphausen, P., Nisius, B., Peltason, L., & Bajorath, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101020z · Cited by 262
Self-citationUse of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254
SAR Index: Quantifying the Nature of Structure−Activity Relationships
Peltason, L., & Bajorath, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0705713 · Cited by 201
Self-citationJanet, J. P., Chan, L., & Kulik, H. J. (2018) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.8b00170 · Cited by 200
Geppert, H., Horváth, T., Gärtner, T., Wrobel, S., & Bajorath, J. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700461s · Cited by 63
Self-citationLeveraging Cheminformatics Strategies for Inorganic Discovery: Application to Redox Potential Design
Janet, J. P., Gani, T. Z. H., Steeves, A. H., Ioannidis, E. I., & Kulik, H. J. (2017) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.7b00808 · Cited by 56
Metadata
- Authors
- Eckert, H., & Bajorath, J.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 12
- Issue
- 5-6
- Pages
- 225-233
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2042007894
- Cited by
- 466
- References
- 46
- FWCI
- 41.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.